#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Carcinoid syndrome Small cell lung cancer Depression Hereditary neuropathic amyloidosis Shprintzen-Goldberg syndrome CDKL5 deficiency disorder Bulbospinal muscular atrophy congenital Osteochondrodysplasia Cardiac failure acute Mitochondrial myopathy Pulmonary tuberculosis Systemic mastocytosis Retinitis pigmentosa Epilepsy with myoclonic-atonic seizures Splenic marginal zone lymphoma More trials…

    Learn about Rare Diseases

    Factor IX deficiency – Basic Information Pleural mesothelioma malignant – Diagnostics Primary immunodeficiency syndrome – Life with Disease Familial amyotrophic lateral sclerosis – Trials in Disease KBG syndrome Haemophilia – Life with Disease Skin angiosarcoma – Diagnostics Glycogen storage disease type II – Trials in Disease Activated PI3 kinase delta syndrome – Basic Information Medulloblastoma recurrent – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Magnesium Oxide, Light Guselkumab Dermatophagoides Pteronyssinus Sodium Valproate Ergocalciferol Bp Laronidase Melphalan Flufenamide Bi 1839100 Cemiplimab Terbinafine AMO959 Ag-946 Phosphate Bi-1910 Salbutamol Bgb-15025 Citrate Phosphocreatine Sodium Imgn151 LY3537021 Imatinib Nimorazole More therapies…

    Learn about Your Condition

    Leukoencephalopathy Cutaneous calcification Peritoneal dialysis Pathogen resistance Procedural anxiety Pancreatitis acute Renal cancer Portal hypertension Hypertrophic scar Plasma cell myeloma recurrent Bronchitis Diabetic autonomic neuropathy Chondroplasty Breast neoplasm Cataract More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

HIV infection

  • Study on the Safety and Effectiveness of Emtricitabine and Tenofovir Alafenamide for HIV-1 Prevention in Men and Transgender Women at Risk

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Emtricitabine
    • Tenofovir Alafenamide
    Austria Denmark France Germany Ireland Italy +1

  • Study on Immune Response to Recombinant Zoster Vaccine in People Over 50 Living with HIV

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Recombinant Varicella Zoster Virus Glycoprotein E
    France

  • Study on the Safety and Effects of Baricitinib in People with HIV

    Not recruiting

    2 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Baricitinib
    Spain

  • Study of Weekly Oral GS-1720 and GS-4182 for Untreated HIV-1 Patients

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • GS-1720
    • Gs-4182
    • Bictegravir
    Germany Poland Portugal Romania Spain

  • Study of Long-Acting Cabotegravir and Rilpivirine for People Aged 60 and Over Living with HIV-1

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Cabotegravir
    • Rilpivirine
    Spain

  • Study on the Effectiveness of Cabotegravir and Rilpivirine for People with HIV-1 Who Have Not Responded Well to Oral Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Cabotegravir
    • Rilpivirine
    Belgium Germany Italy Portugal Spain
Previous Page
1 … 4 5 6 7 8 … 12
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!